5 min
Medication for Obesity: A Swift Synopsis Dr. Journal Club
-
- Medicine
Join us for a rapid-fire review of a groundbreaking study published in The Lancet by McMaster University. Explore the latest insights on weight loss treatments alongside esteemed scholars like Gordon Guyatt and Per Van Vick. With Dr. Goldenberg guiding us through the study's complexities, we quickly unpack findings from 143 trials involving nearly 50,000 participants. Witness the clash of heavyweight medications like the fentermine-topiramate combo, GLP-1 agonists, and naltrexone-bupropion duo, as they vie for supremacy in the battle against obesity. Don't miss out on this fast-paced discussion shedding light on the efficacy and safety of these interventions, offering clarity in the realm of weight loss treatments.
Learn more and become a member at www.DrJournalClub.com
Check out our complete offerings of NANCEAC-approved Continuing Education Courses.
Join us for a rapid-fire review of a groundbreaking study published in The Lancet by McMaster University. Explore the latest insights on weight loss treatments alongside esteemed scholars like Gordon Guyatt and Per Van Vick. With Dr. Goldenberg guiding us through the study's complexities, we quickly unpack findings from 143 trials involving nearly 50,000 participants. Witness the clash of heavyweight medications like the fentermine-topiramate combo, GLP-1 agonists, and naltrexone-bupropion duo, as they vie for supremacy in the battle against obesity. Don't miss out on this fast-paced discussion shedding light on the efficacy and safety of these interventions, offering clarity in the realm of weight loss treatments.
Learn more and become a member at www.DrJournalClub.com
Check out our complete offerings of NANCEAC-approved Continuing Education Courses.
5 min